NATIONAL CANNABIS BAR ASSOCIATION
US HEMP ROUNDTABLE
Last week, after learning that Senator Chuck Grassley filed an amendment to the Farm Bill which might have restricted the sale of hemp-derived products such as CBD, we asked you to take action.
You responded. Wow, did you respond! By the next morning, you broke the Internet – more than 100,000 social media interactions, and just through our online portal alone, you sent 23,453 emails to US Senators.
It worked. The Farm Bill passed out of the Senate Agriculture Committee, with the full Hemp Farming Act, with only one no vote.
BUT WE ARE NOT DONE YET! Senate Majority Leader McConnell expects the Farm Bill to pass the full Senate before July 4. However, we can’t take any chances. And we need to get prepared for the House’s consideration of the Farm Bill later this summer.
Because of your actions, now even Senator Grassley proclaims himself “pro-hemp.” However, as summarized in this letter he later sent to a constituent, Grassley incorrectly asserts that the Hemp Farming Act would open up a Wild West of sorts for CBD – there would be no regulation of any sorts, and harmful products could injure vulnerable children.
We have adjusted our online portal to urge Senators to reject any future efforts to weaken the permanent legalization of hemp and hemp-derived products like CBD. Here is our message:
Please help us. Even if you sent an email last week, return to our online portal to send a new message to your Senators to be vigilant against weakening of the Farm Bill. And please share this message and our portal with your friends, customers and social media contacts.
Reminder: your experts at California Cannabis CPAs are getting a new name! We are re-branding to Green Growth CPAs with a new site and blog page. Add our new email address to ensure these updates don’t get lost in spam: firstname.lastname@example.org.
Now, on to today’s news!
Today’s Top News
- Montebello recently approved a second reading of ordinances related to a zoning code amendment. This amendment was related to cannabis distribution and delivery-only places of business.
- On July 1, California will begin enforcing strict testing and packaging regulations that require all cannabis goods to be tested at approved labs.
- CLICK THROUGH for a list of California cities with rolling application deadlines!
To All Interested Parties:
On June 18, 2018, the State Licensing Authority adopted emergency Medical and Retail Marijuana rules, for which the Statement of Emergency Justification and Adoption can be found on our MED Rules website. The purposes of the revisions and/or additions to the Medical and Retail Marijuana rules on an emergency basis are to establish requirements and procedures to implement the following legislation, all of which became effective immediately upon the Governor’s signature pursuant to a safety clause:
House Bill 18-1280
House Bill 1280 requires persons appointed by a court to take possession of, operate, manage, or control a Medical Marijuana Business or Retail Marijuana Establishment to notify the State Licensing Authority and apply for a finding of suitability. Further, it requires the State Licensing Authority, upon notification of such court appointments, to issue a temporary registration to the court appointee. The amended M and R 100, 200, and 1700 Series Rules establish definitions, fees, procedures, and temporary registration requirements for persons authorized by court order to take possession of, operate, manage, or control a Medical Marijuana Business or Retail Marijuana Establishment.
House Bill 18-1389
House Bill 1389 establishes a centralized distribution permit to be issued to Medical Marijuana Optional Premises Cultivation Operations (“Medical Cultivation”) and Retail Marijuana Cultivation Facilities (“Retail Cultivation”), authorizing temporary storage of medical and retail marijuana, concentrate, and product, for the purpose of transfer to the permit holder’s commonly-owned Medical Marijuana Centers and Retail Marijuana Stores. The amended M and R 100 and 500 Series Rules establish definitions, fees, requirements, and procedures for Medical Cultivations and Retail Cultivations applying for and issued a Centralized Distribution Permit.
Senate Bill 18-271
Senate Bill 271 authorizes Marijuana Research and Development Facility and Marijuana Research and Development Cultivation (“Licensed Research Businesses”) to share licensed premises with a Medical Marijuana-Infused Products Manufacturer and Retail Marijuana Products Manufacturing Facility. Under prior law, such co-location was restricted, as medical and retail marijuana products could only be prepared on a licensed premises used exclusively for the manufacture and preparation of medical and retail products and using equipment exclusively for the manufacture and preparation of such products. As a result, research activities of a Licensed Research Business could not occur at the same premises of a medical or retail manufacturing licensee, and the rules had not to date set forth the process for a Licensed Research Business to share a licensed premises with other types of Medical Marijuana Businesses and Retail Marijuana Establishments. The amended M and R 100 200, 300, 600, and 1300 Series Rules, and amended M 1900 Series Rules, establish fees, requirements, and procedures for Licensed Research Businesses sharing a licensed premises with another Medical Marijuana Business or a Retail Marijuana Establishment. Further, Senate Bill 271 authorizes the State Licensing Authority to establish requirements for transfer of marijuana by Licensed Research Businesses. The amended M 1900 Series Rules permit the transfer of Immature Plants to other Medical Marijuana Businesses, so long as the plants have not been exposed to prohibited chemicals.
The emergency rules are effectively immediately. Following the adoption of these emergency rules, the State Licensing Authority will initiate permanent rulemaking proceedings, which will include the opportunity for substantial stakeholder and public participation.
As part of the State Licensing Authority’s permanent rulemaking proceedings, the Division is facilitating work group meetings. The Stakeholder work groups include :
Additional information regarding the work groups, meeting dates and opportunities for participation can be located on the Division’s 2018 Rulemaking website.
The Marijuana Enforcement Division
Title: Oregon Appeals Court Rejects Restrictions Imposed by County on Marijuana Growers
Date: 15 June 2018
SALEM, Ore. (AP) — The Oregon Court of Appeals rejected an appeal by county commissioners in a prime cannabis-growing part of the state to put back in place their restrictions on commercial marijuana production.
The appeals court’s dismissal without comment Wednesday, June 13, 2018, of the Josephine County commissioners’ case marks the latest step in the struggle between the county’s political leaders to tamp down the proliferating cannabis industry, and growers trying to protect their businesses and investments.
In December, the county commission passed an ordinance banning commercial pot farming on smaller rural residential lots, and reducing larger grow sites.
Ross Day, attorney for the marijuana farmers, said the county’s appeal to the court was frivolous.
“Hopefully the county gets the message that it acted illegally when it adopted the ordinance,” Day said after the Oregon Court of Appeals made its ruling.
Title: Republican Party Of Texas Declines To Make Medical Cannabis A Priority
Author: Texas Cannabis Report
Date: 18 June 2018
Those seeking to gain ground within the Republican Party of Texas concerning medical cannabis can consider this past week’s state convention to be a win, but that doesn’t mean the party intends to take the issue on as a priority.
Party delegates voted to add planks to the platform which support expanding Texas’ current medical cannabis program, decreasing the penalty for possession of an ounce of marijuana to a $100 fine without jail time, hemp legalization, and calling for the federal government to re-schedule the plant. All passed with between 82 percent to 90 percent support.
According to a release by Texas NORML, medical cannabis seems to have fallen short of being listed as a priority for the upcoming session.